Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 3

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 3
---
 sale is not permitted or in which the person making that offer or solicitation
is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. You should assume that the information
appearing in this prospectus supplement, the documents incorporated by reference in this prospectus supplement, the accompanying base
prospectus and any free writing prospectus that we have authorized for use in connection with this offering, is accurate only as of the
date of those respective documents. Our business, financial condition, results of operations and prospects may have changed since those
dates. You should read this prospectus supplement, the accompanying prospectus, the documents incorporated by reference in this prospectus
supplement and any free writing prospectus that we have authorized for use in connection with this offering, in their entirety before
making an investment decision.

We further note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus
supplement and the accompanying prospectus were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or
covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such
representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.

All references to “Journey,” the “Company,”
“we,” “us,” and “our” refer to Journey Medical Corporation.

<div align='center'>S-1</div>

PROSPECTUS SUPPLEMENT SUMMARY The following is a summary of what we believe to be the most important aspects of our business and the offering of our common stock under this prospectus supplement. We urge you to read this entire prospectus supplement, including the more detailed consolidated financial statements, notes to the consolidated financial statements and other information incorporated by reference from our other filings with the SEC or included in any applicable prospectus supplement. Investing in our common stock involves risks. Therefore, carefully consider the risk factors set forth in any prospectus supplements and in our most recent Annual Report on Form 10-K and in our most recent Quarterly Reports on Form 10-Q filed with the SEC, as well as any amendments thereto reflected in subsequent filings with the SEC, and any other information in this